In 2023, the hospital discharges for malignant neoplasm of the prostate in Italy stood at 90.0 units per hundred thousand persons. From 2024 to 2028, the forecasted data shows a gradual increase: 90.5 in 2024, 91.3 in 2025, 92.0 in 2026, 92.6 in 2027, and 93.0 in 2028. The year-on-year variation shows slight increments: 0.56% from 2024 to 2025, 0.77% from 2025 to 2026, 0.65% from 2026 to 2027, and 0.43% from 2027 to 2028. The compound annual growth rate (CAGR) over the five years from 2023 to 2028 stands at 0.66%.
Future trends to watch for:
- Potential impact of advances in medical technology and prostate cancer treatment
- Changes in healthcare policy and prostate cancer screening practices
- Demographic shifts, particularly aging population trends
- Increased awareness and early detection efforts
